Tag:
Kevin Bitterman
Latest Headlines
Latest Headlines
This could be the year of nanotech-enabled medicines
Nanotech-enabled medicines are coming of age. That's the big message I came away with after a recent telephone chat with Kevin Bitterman, a life sciences investor with Polaris Venture Partners in
